Search results
Alzheimer's drug study yields positive results, say makers Eisai and Biogen
Reuters via Yahoo News· 2 years agoAn experimental Alzheimer's drug made by Eisai Co Ltd and Biogen slowed cognitive and functional...
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Benzinga via Yahoo Finance· 2 years agoEisai Co Ltd (OTC: ESALY) has completed the rolling submission of the FDA marketing application...
FDA decision on Eisai, Biogen Alzheimer's drug due in January
Reuters via Yahoo News· 2 years ago(Reuters) -The U.S. Food and Drug Administration will expedite its review of Eisai Co Ltd's and...
Eisai files for full FDA approval for Alzheimer's drug Leqembi
Reuters via Yahoo Finance· 1 year ago(Reuters) - Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the...
Eisai, Biogen say FDA grants priority review for Alzheimer's drug Lecanemab
Reuters via Yahoo News· 1 year agoTOKYO (Reuters) - Japanese drugmaker Eisai Co Ltd and its U.S. partner Biogen Inc said on Monday...
Eisai, Biogen say Alzheimer's drug Lecanemab getting priority review in China
Reuters via Yahoo News· 1 year agoTOKYO (Reuters) - Japanese drugmaker Eisai Co Ltd and U.S. biotech firm Biogen Inc said on Tuesday...
Eisai, Biogen get U.S. FDA approval for Alzheimer's drug, apply for full approval
Reuters via Yahoo Finance· 1 year ago(Reuters) -The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug lecanemab...
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Benzinga via Yahoo Finance· 1 year agoEisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) announced that three additional detailed...
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Benzinga via Yahoo Finance· 1 year agoThe FDA has accepted Eisai Co Ltd (OTC: ESALY) and Biogen Inc's (NASDAQ: BIIB) supplemental...
Eisai says Alzheimer's drug succeeds in slowing cognitive decline
Reuters via Yahoo Finance· 2 years agoAn experimental Alzheimer's drug developed by Eisai Co Ltd and Biogen Inc significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease ...